重大消息！！
今天我从美国病友那里得到了重大消息！！！！
乙肝病毒就要治愈！！ 药已经发明出来了。 请看以下消息
加拿大温哥华太阳报最新消息！！！！
人类医学的重大进展！！
病毒早晚会被攻克！！ 我们疱疹战友就快得救了。 悲观的朋友能否不再悲观了？？
没时间翻译， 你们自己下点功夫看吧！！
真的是好消息啊， 迷糊第一时间发给你们， 我自己都很兴奋， 下一个攻克的一定就是疱疹啦！！！
大家就要见光明啦
主保佑
迷糊
Drug combo boosts hepatitis C cure
Method cuts treatment time and improves outcome: study
By Sharon Kirkey, Postmedia News With Files From Andrea Woo, Vancouver Sun March 31, 2011 A triple drug combination can eliminate hepatitis C in both the newly infected as well as the hardest-to-treat patients, according to research involving more than 100 Canadian patients.
Two studies published this week in the New England Journal of Medicine show that adding the experimental drug boceprevir to two standard drugs reduced the virus to undetectable levels in significantly more patients than standard therapy alone. The triple drug regimen also cut treatment time by as much as half.
B.C. has the highest rate of hepatitis C infection in Canada, with about 60,000 chronic cases, according to Dr. Mel Krajden, director of hepatitis services at the BC Centre for Disease Control.
"Our rates are about twice as high as the rates of the general population in Canada, likely because there's more injection drug use in B.C.," Krajden said.
In Canada, an estimated quarter of a million people are infected with hepatitis C; one in five are unaware they're infected, because symptoms are often "silent." Worldwide, more than 170 million people are infected with hepatitis C.
The virus attacks the liver and can be fatal. About half of all liver transplants in Canada are due to hepatitis C.
Current therapy for genotype I hepatitis C -the most common form of the virus -involves a once-weekly injection of peginterferon, plus ribavirin, a pill taken daily, for 48 weeks. But only about 40 per cent of patients clear the virus after treatment, said Dr. Mark Levstik, an associate professor in the department of medicine at the University of Western Ontario in London and investigator in one of the trials.
"That leaves us with almost 60 per cent of patients who don't respond, which is significant," Levstik said.
Hepatitis C treatments cost an average of $20,000, depending on the type of virus and genotype.
About one in five patients can't get through treatment because of sideeffects such as profound fatigue, body aches and other flu-like symptoms.
Boceprevir -which is not yet approved for use by the FDA or Health Canada -is a protease inhibitor, which works directly on the virus. It is not yet known how much it might cost.
The two new studies, funded by drug maker Merck, involved a total of 1,500 patients, 146 of them recruited from Canada. The studies involved patients who had never before been treated for hepatitis C and those for whom standard therapy had failed.
According to the results, adding boceprevir resulted in as many as 66 per cent of patients having no detectable virus in their blood after treatment, compared to 21 per cent to 38 per cent of those who received the standard two-drug combination alone.
"They're done therapy, you check six months later and there's no virus," said Levstik. "Their liver tests are normal."
"When we've looked traditionally at those patients one, two, five, 10 years later, despite all sorts of other medical problems, the virus never comes back. So it's essentially a clinical cure."
Many patients on the triple therapy were able to stop treatment after 28 weeks -20 weeks shorter than normal.
Krajden said the effectiveness of the new drug combination is not surprising, as the curability of hepatitis is getting "better and better."
"There is a whole slew of new agents that are in the therapeutic pipeline that are going to make hep C a curable illness in the next five years or so," he said.
Rates of anemia were higher among patients receiving the boceprevircontaining regimens.
But, "we've got a medication now that is significantly more efficacious, we're going to clear significantly more [patients] of the virus, and we have the ability to shorten therapy," Levstik said.
"The effects on their quality of life, their family, their work, is significantly reduced."
Hepatitis C can go undetected for years. The virus is spread primarily through contact with the blood of an infected person.
In the past, many people became infected through contaminated blood or blood products.
The virus can be spread via injection drug use, tattoos or body piercing, acupuncture using unsterile equipment, sharing razor blades and toothbrushes and needle-stick injuries in hospitals.
"People pop up with having this antibody for hepatitis C or they have abnormal liver tests," he says. "We've got bankers, lawyers, doctors -all sorts of walks of life."
Read more:
http://www.vancouversun.com/health/Drug+combo+boosts+hepatitis+cure/4533775/story.html#ixzz1M1ySBGH0
